Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jinhui Wang, Wei Wang, Jichen Li, Liji Wu, Mei Song & Qinggang Meng. (2017) miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1. OncoTargets and Therapy 10, pages 667-679.
Read now
Read now
Assuntina G Sacco & Francis P Worden. (2016) Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors. OncoTargets and Therapy 9, pages 1927-1943.
Read now
Read now
Antti A Mäkitie & Outi Monni. (2009) Molecular profiling of laryngeal cancer. Expert Review of Anticancer Therapy 9:9, pages 1251-1260.
Read now
Read now
Articles from other publishers (39)
João Figueira Scarini, Luccas Lavareze, Reydson Alcides de Lima-Souza, Carolina Emerick, Mayara Trevizol Gonçalves, Tayná Figueiredo-Maciel, Gustavo de Souza Vieira, Talita de Carvalho Kimura, Raisa Sales de Sá, Iara Gonçalves Aquino, Patricia Maria Fernandes, Luiz Paulo Kowalski, Albina Altemani, Fernanda Viviane Mariano & Erika Said Abu Egal. (2022) Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy. Critical Reviews in Oncology/Hematology 180, pages 103863.
Crossref
Crossref
Nikita Aggarwal, Joni Yadav, Suhail Chhakara, Divya Janjua, Tanya Tripathi, Apoorva Chaudhary, Arun Chhokar, Kulbhushan Thakur, Tejveer Singh & Alok Chandra Bharti. (2021) Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects. Frontiers in Pharmacology 12.
Crossref
Crossref
Hao Zeng, Xindi Song, Jianrui Ji, Linyan Chen, Qimeng Liao & Xuelei Ma. (2020) HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC. BMC Cancer 20:1.
Crossref
Crossref
Yue Yin, Yingyun Tan, Yuan Yao, Na Lu & Fugui Zhang. (2020) SNHG12/miR‐326/E2F1 feedback loop facilitates the progression of oral squamous cell carcinoma. Oral Diseases 26:8, pages 1631-1639.
Crossref
Crossref
Mehdi Aali, Ali Hossein Mesgarzadeh, Shiva Najjary, Hossein Mashhadi Abdolahi, Amir Baghbanzadeh Kojabad & Behzad Baradaran. (2020) Evaluating the role of microRNAs alterations in oral squamous cell carcinoma. Gene 757, pages 144936.
Crossref
Crossref
Xuegang Hu, Guanwen Sun, Zhiqiang Shi, Hui Ni & Shan Jiang. (2020) Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis. PeerJ 8, pages e8505.
Crossref
Crossref
Julian Künzel, Alena Gribko, Qiang Lu, Roland H. Stauber & Désirée Wünsch. (2019) Nanomedical detection and downstream analysis of circulating tumor cells in head and neck patients. Biological Chemistry 400:11, pages 1465-1479.
Crossref
Crossref
Yanyan Zhu, Chaojie Wang, Yun Zhou, Ning Ma & Jianwei Zhou. (2018) C6 ceramide motivates the anticancer sensibility induced by PKC412 in preclinical head and neck squamous cell carcinoma models. Journal of Cellular Physiology 233:12, pages 9437-9446.
Crossref
Crossref
Xuegang Hu, Zailing Qiu, Jianchai Zeng, Tingting Xiao, Zhihong Ke & Hongbing Lyu. (2018) A novel long non-coding RNA, AC012456.4, as a valuable and independent prognostic biomarker of survival in oral squamous cell carcinoma. PeerJ 6, pages e5307.
Crossref
Crossref
Jun-ying Wang, Xin Jin, Xin Zhang & Xiao-feng Li. (2018) CC-223 inhibits human head and neck squamous cell carcinoma cell growth. Biochemical and Biophysical Research Communications 496:4, pages 1191-1196.
Crossref
Crossref
Jing Xie, Quan Li, Xi Ding & Yunyun Gao. (2017) GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway. Oncotarget 8:31, pages 50814-50823.
Crossref
Crossref
Jonathan Moreira, Alexander Tobias, Michael P. O’Brien & Mark Agulnik. (2017) Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies. Drugs 77:8, pages 843-857.
Crossref
Crossref
Alexandre Bozec, Nathalie Ebran, Nina Radosevic-Robin, Emmanuel Chamorey, Hedi Ben Yahia, Serge Marcie, Mathieu Gautier, Frédérique Penault-Llorca & Gérard Milano. (2017) Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer. Head & Neck 39:1, pages 151-159.
Crossref
Crossref
Yi Li & Jiang-Tao Cui. (2016) Inhibition of Bcl-2 potentiates AZD-2014-induced anti-head and neck squamous cell carcinoma cell activity. Biochemical and Biophysical Research Communications 477:4, pages 607-613.
Crossref
Crossref
Yajuan Zhou, Yi Peng, Hao Tang, Xiaojun He, Zhaohua Wang, Desheng Hu & Xiaoyi Zhou. (2016) Autophagy induction contributes to GDC-0349 resistance in head and neck squamous cell carcinoma (HNSCC) cells. Biochemical and Biophysical Research Communications 477:2, pages 174-180.
Crossref
Crossref
Cécile Charles, Catherine Bungener, Darius Razavi, Christine Mateus, Emilie Routier, Emilie Lanoy, Michèle Verschoore, Caroline Robert & Sarah Dauchy. (2016) Impact of dermatologic adverse events induced by targeted therapies on quality of life. Critical Reviews in Oncology/Hematology 101, pages 158-168.
Crossref
Crossref
Shyhmin Huang, H. Peter Rodemann & Paul M. Harari. 2016. Molecular Radio-Oncology. Molecular Radio-Oncology
45
87
.
Arutha Kulasinghe, Chris Perry, Lidija Jovanovic, Colleen Nelson & Chamindie Punyadeera. (2015) Circulating tumour cells in metastatic head and neck cancers. International Journal of Cancer 136:11, pages 2515-2523.
Crossref
Crossref
Jinyi Lang, Li Gao, Ye Guo, Chong Zhao & Chenping Zhang. (2014) Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013. Future Oncology 10:9, pages 1635-1648.
Crossref
Crossref
A. Bozec, G. Poissonnet, C.S. Pierre, J. Santini & O. Dassonville. (2014) Cancro dell’orofaringe. EMC - Otorinolaringoiatria 13:1, pages 1-17.
Crossref
Crossref
A. Bozec, G. Poissonnet, C.S. Pierre, J. Santini & O. Dassonville. (2014) Cáncer de la orofaringe. EMC - Otorrinolaringología 43:1, pages 1-18.
Crossref
Crossref
Qiang Li, Xin-mao Song, Yang-yang Ji, Hui Jiang & Lin-gen Xu. (2013) The dual mTORC1 and mTORC2 inhibitor AZD8055 inhibits head and neck squamous cell carcinoma cell growth in vivo and in vitro. Biochemical and Biophysical Research Communications 440:4, pages 701-706.
Crossref
Crossref
Alexandre Bozec, Marius Ilie, Olivier Dassonville, Elodie Long, Gilles Poissonnet, José Santini, Emmanuel Chamorey, Marc Ettaiche, Damien Chauvière, Frédéric Peyrade, Christophe Hebert, Karen Benezery, Anne Sudaka, Juliette Haudebourg, Eric Selva & Paul Hofman. (2013) Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology 270:10, pages 2745-2749.
Crossref
Crossref
A. Bozec, G. Poissonnet, J. Santini & O. Dassonville. (2013) Cancro dell’ipofaringe. EMC - Otorinolaringoiatria 12:2, pages 1-17.
Crossref
Crossref
Daisuke Soga. (2013) microRNA expression profiles in oral squamous cell carcinoma. Oncology Reports.
Crossref
Crossref
Meng Tong, Byungdo B. Han, Andrew S. Holpuch, Ping Pei, Lingli He & Susan R. Mallery. (2013) Inherent phenotypic plasticity facilitates progression of head and neck cancer: Endotheliod characteristics enable angiogenesis and invasion. Experimental Cell Research 319:7, pages 1028-1042.
Crossref
Crossref
A. Bozec, G. Poissonnet, J. Santini & O. Dassonville. (2013) Cáncer de la hipofaringe. EMC - Otorrinolaringología 42:2, pages 1-18.
Crossref
Crossref
A. Bozec, G. Poissonnet, J. Santini & O. Dassonville. (2013) Cancer de l’hypopharynx. EMC - Oto-rhino-laryngologie 8:1, pages 1-17.
Crossref
Crossref
Yan-li Yang, Chao Ji, Zhi-gang Bi, Chun-cheng Lu, Rong Wang, Bing Gu & Lei Cheng. (2013) Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells. PLoS ONE 8:1, pages e54736.
Crossref
Crossref
Luca Calabrese, Angelo Ostuni, Mohssen Ansarin, Gioacchino Giugliano, Fausto Maffini, Daniela Alterio, Maria Cossu Rocca, Giuseppe Petralia, Roberto Bruschini & Fausto Chiesa. (2012) Future challenges in head and neck cancer: From the bench to the bedside?. Critical Reviews in Oncology/Hematology 84, pages e90-e96.
Crossref
Crossref
Ajay Matta & Ranju Ralhan. 2012. Controversies in Oral Cancer. Controversies in Oral Cancer
1
16
.
Benjamin Lallemand, Fabien Chaix, Marina Bury, Céline Bruyère, Jean Ghostin, Jean-Paul Becker, Cédric Delporte, Michel Gelbcke, Véronique Mathieu, Jacques Dubois, Martine Prévost, Ivan Jabin & Robert Kiss. (2011)
N
-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (
6b
): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity
. Journal of Medicinal Chemistry 54:19, pages 6501-6513.
Crossref
Crossref
Alexandre Bozec, Anne Sudaka, Marie-Christine Etienne-Grimaldi, Marie-Christine Brunstein, Jean-Louis Fischel & Gérard Milano. (2011) Antitumor activity of cetuximab associated with the taxotere–cisplatin–fluorouracil (TPF) combination on an orthotopic head and neck cancer model. Oral Oncology 47:10, pages 940-945.
Crossref
Crossref
Marianne E. Marshall, Trista K. Hinz, Scott A. Kono, Katherine R. Singleton, Brady Bichon, Kathryn E. Ware, Lindsay Marek, Barbara A. Frederick, David Raben & Lynn E. Heasley. (2011) Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells. Clinical Cancer Research 17:15, pages 5016-5025.
Crossref
Crossref
Balázs Szabó, Györgyi A. Nelhűbel, Adél Kárpáti, István Kenessey, Balázs Jóri, Csilla Székely, István Peták, Gábor Lotz, Zita Hegedűs, Balázs Hegedűs, Tibor Füle, Balázs Döme, József Tímár & József Tóvári. (2011) Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncology 47:6, pages 487-496.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Otolaryngology & Head & Neck Surgery 18:2, pages 134-145.
Crossref
Crossref
Károly Lapis. (2010) Gazdavédő peptidek és peptidomimetikumok, mint a rákterápia potenciális új eszközeiHost defense peptides and peptidomimetics as new weapons for cancer treatment. Magyar Onkológia 54:1, pages 47-58.
Crossref
Crossref
Yoon Woo Koh. (2010) Combinatorial Targeted Therapy in Thyroid Cancer. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 53:4, pages 203.
Crossref
Crossref
Quynh-Thu Le & Jiade J. Lu. 2010. Nasopharyngeal Cancer. Nasopharyngeal Cancer
27
40
.